BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Abdominal Symptom Phenotype Study in Children
Completed
- Conditions
- Irritable Bowel Syndrome (IBS)
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 45
- Registration Number
- NCT01204515
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Pilot RCT of an Obesity Intervention for Primary Care Pediatrics: Helping HAND
Not Applicable
Completed
- Conditions
- Childhood Obesity
- Interventions
- Behavioral: Helping HAND (Healthy Nutrition and Activity Directions)
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT01195012
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
Phase 1
Active, not recruiting
- Conditions
- Neuroblastoma
- Interventions
- Biological: Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT01192555
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
Phase 1
Active, not recruiting
- Conditions
- Non-Hodgkin's LymphomaHodgkin's Lymphoma
- Interventions
- Drug: autologous CAR.CD30 EBV specific-CTLs
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT01192464
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
Not Applicable
Recruiting
- Conditions
- AllogeneicStem Cell Transplant
- Interventions
- Device: CliniMACS CD34 Reagent system
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 241
- Registration Number
- NCT01189786
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Pharmacogenetics of Doxazosin for Cocaine Dependence
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 96
- Registration Number
- NCT01145183
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
Phase 1
Completed
- Conditions
- Glioblastoma Multiforme (GBM)
- Interventions
- Biological: HER.CAR CMV-specific CTLs
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT01109095
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Test of an Intervention to Improve HIV Care
Not Applicable
Completed
- Conditions
- HIV Infection
- Interventions
- Behavioral: Patient Mentor InterventionBehavioral: HIV transmission risk reduction
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 460
- Registration Number
- NCT01103856
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Bladder Cancer Patient-Reported Outcomes
Completed
- Conditions
- Bladder Neoplasms
- First Posted Date
- 2010-03-22
- Last Posted Date
- 2016-11-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 108
- Registration Number
- NCT01090388
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Rivastigmine as a Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Methamphetamine DependenceSubstance AbuseMethamphetamine Abuse
- Interventions
- Other: Placebo
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT01073319
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath